EcoDrugPlus

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSTOG00000019997
Gene Symbol: PTGDR2
3 Cross references
206 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSSTOG00000013787
Gene Symbol: PTGER1
3 Cross references
235 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSSTOG00000026921
Gene Symbol: PTGER2
4 Cross references
241 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSSTOG00000000886
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSSTOG00000024710
Gene Symbol: PTGER4
4 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSSTOG00000001209
Gene Symbol: PTGFR
4 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSSTOG00000023648
Gene Symbol: PTGIR
4 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSSTOG00000001672
Gene Symbol: PTGS1
4 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSSTOG00000009613
Gene Symbol: PTGS2
2 Cross references
236 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSSTOG00000006270
Gene Symbol: PSMA1
3 Cross references
254 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSSTOG00000013334
Gene Symbol: PSMA2
3 Cross references
222 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSSTOG00000013539
Gene Symbol: PSMA3
3 Cross references
225 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).